<DOC>
	<DOCNO>NCT00125060</DOCNO>
	<brief_summary>This research do investigate ability experimental imaging method - transesophageal magnetic resonance imaging ( TEMRI ) , detect change aortic atherosclerotic plaque burden morphology patient high dose cholesterol lower medication patient standard dose cholesterol lower medication . This study use TEMRI see atherosclerosis ( cholesterol build ) change cholesterol lower medication . This study also investigate whether cholesterol-lowering medication change level blood test , call inflammatory marker , patient â€™ blood . People atherosclerosis may join study . This study also store blood sample future study cardiac disease ; gene test do .</brief_summary>
	<brief_title>Transesophageal Magnetic Resonance Imaging ( MRI ) Conjunction With Lipid Lowering Measures</brief_title>
	<detailed_description>Using new MRI coil develop Hopkins researcher , investigator able image aortic atherosclerotic plaque exquisite detail . This coil place esophagus via small nasogastric tube position next descending thoracic aorta . Using method transesophageal MRI ( TEMRI ) , investigator able measure extent aortic atherosclerosis size individual plaque , image detail obtain information plaque composition . The extent aortic atherosclerosis correlate cardiovascular event include heart attack stroke . The investigator propose use new imaging technique study effect aggressive lipid lower measure patient aortic atherosclerosis . They plan randomize patient document vascular disease high dose ( simvastatin 80mg ) versus low dose ( simvastatin 20mg ) cholesterol lower medication . The investigator expect show decrease extent atherosclerosis , change plaque morphology composition , perhaps decrease cardiovascular event aggressive care group patient . They also plan measure serum marker inflammation patient baseline therapy . C-reactive protein study marker independently correlate cardiovascular event . The investigator hope show TEMRI correlate high level C-reactive protein baseline atherosclerosis , treatment high dose statin therapy reduces level inflammatory marker . Finally plan store plasma collected patient save future study cardiac marker , could correlate effect statin therapy reduction aortic atherosclerosis document TEMRI .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Age great 18 year Required documented atherosclerosis least 1 vascular territory define : least moderate ( &gt; 3.9mm ) aortic atherosclerosis see transesophageal echocardiography ; moderate coronary artery disease ( &gt; 50 % lesion ) least 1 coronary artery see cardiac catheterization ; &gt; 50 % carotid lesion see ultrasound ; clinically document peripheral vascular disease . Patients could statin therapy entry , dose equivalent great 80mg simvastatin . Patients pacemaker , automate implanted cardioverter defibrillator ( AICD ) , aneurysm clip , abnormal nasopharyngeal anatomy , active peptic ulcer disease , severe dysphagia , elevate baseline liver transaminases serum creatinine ( great 2 time normal ) , decompensated congestive heart failure inability give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2004</verification_date>
	<keyword>Aorta</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>MRI</keyword>
	<keyword>statin</keyword>
	<keyword>inflammatory marker</keyword>
</DOC>